IR
66
3
NWL
53
3
NOC
43
11
WM
79
3
PRGO
39
3
FITB
63
3
AN
58
4
TXT
55
3
HPE
63
2
PM
62
-2
HBI
59
4
NSC
60
3
RIG
60
2
PBI
69
4
WBA
48
4
LNC
39
3
HST
49
-9
SNA
68
-2
CRM
67
2
DHI
48
4
IR
66
3
NWL
53
3
NOC
43
11
WM
79
3
PRGO
39
3
FITB
63
3
AN
58
4
TXT
55
3
HPE
63
2
PM
62
-2
HBI
59
4
NSC
60
3
RIG
60
2
PBI
69
4
WBA
48
4
LNC
39
3
HST
49
-9
SNA
68
-2
CRM
67
2
DHI
48
4
Financhill
Back

Exicure Vs. Perspective Therapeutics Industry Stock Comparison

Buy
62

XCUR
Exicure

Last Price:
18.56
Seasonality Move:
-3.8%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Buy
62
Exicure (XCUR) is a Buy

Is Exicure a Buy, Sell or Hold?

  • The current Exicure [XCUR] share price is $18.38. The Score for XCUR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • XCUR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XCUR Stock Price Chart

What is Exicure's stock price today?

  • The Exicure share price today is $18.38
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XCUR is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

XCUR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.3 Buy
Relative Strength Index (14 RSI): 92.09 Buy
Chaikin Money Flow: 2764569 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.52 - 7.9) Buy
Bollinger Bands (100): (0.71 - 4.91) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

XCUR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.37 Buy
20-day SMA: 4.64 Buy
50-day SMA: 3.6 Buy
200-day SMA: 2.71 Buy
8-day EMA: 9.23 Buy
20-day EMA: 5.94 Buy
50-day EMA: 4.08 Buy
200-day EMA: 3.22 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

Exicure Earnings Growth & XCUR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Exicure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):